OBS! Ansökningsperioden för denna annonsen har
passerat.
Arbetsbeskrivning
Highly skilled Scientific Advisor in a temporary position
We are in an urgent need of additional help and are looking for a warm and highly skilled person who can help us out. So, if you find that interesting, we have a short-term temporary position to offer.
As a Scientific Advisor you will be involved in proposing study designs for our customer projects, analyse and interpret data, along with writing a scientific reporting of the project outcome.
You will also work tight with our commercial team, providing scientific support, attend customer meetings to discuss project-specific challenges / opportunities.
To be successful in this role, we see that you are a team player who finds it important to share ideas and experience with your colleagues to develop the company and its business, but also enjoying working together with us as a team contributing with a positive attitude.
You will report to the CEO.
Qualifications
You would probably have
- a Master´s Degree in Immunology or Toxicology. A PhD degree is preferred.
- Solid experience in medical reporting.
- A good understanding in Laboratory analytical methods like Flow cytometry, ELISA & cell-lines.
- Good knowledge and skills in Excel/Word. Skills in GraphPad or Flow cytometry analysis software is a merit.
- Good verbal and writing skills in Swedish and English.
If you are the right one, please submit your application as soon as possible. If you have any questions about this position and the Company, please contact us at career@immuneed.com
We are reviewing applications on a continuous basis and are looking to hire the right person as soon as possible, send your application today!
Application deadline for this job is February 13th 2022.
Immuneed, Uppsala
With a unique combination of strong scientific knowledge and a versatile and preclinical platform, we provide tailored solutions in the early stages of drug development, providing the customer with essential information on the efficacy and safety of novel drug candidates.